Dr Agarwals Eye Hospital Board of Directors

Get the latest insights into the leadership at Dr Agarwals Eye Hospital. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Amar Agarwal Chairman & Managing Director
Dr.(Mrs.) Athiya Agarwal Whole Time Director
Dr. Adil Agarwal Director
CA. Sanjay Anand Independent Director
Mrs. Latha Ramanathan Independent Director
CA. Balakrishnan Venkataraman Independent Director

Dr Agarwals Eye Hospital Share price

DRAGARWQ

4504.95

2.05 (-0.05%)
Last updated on 4 Sep, 2025 | 15:49 IST
BUYSELL
Today's High

4580.95

Today's Low

4500.10

52 Week Low

3500.00

52 Week High

7300.00

The current prices are delayed, login to your account for live prices

Dr Agarwals Eye Hospital FAQs

The board at Dr Agarwals Eye Hospital consists of experienced professionals, including Dr. Amar Agarwal , Dr.(Mrs.) Athiya Agarwal , and others, overseeing the company’s strategic and corporate governance.

Directors at Dr Agarwals Eye Hospital are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Amar Agarwal is the current chairman at Dr Agarwals Eye Hospital.

Executive directors at Dr Agarwals Eye Hospital are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Dr Agarwals Eye Hospital adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Dr Agarwals Eye Hospital, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.